Open Access 26.05.2017 | Erratum
Erratum to: Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index
Erschienen in: Advances in Therapy | Ausgabe 7/2017
Open Access 26.05.2017 | Erratum
Erschienen in: Advances in Therapy | Ausgabe 7/2017